Pharmaceutical
Biopharmaceutical
Biotechnology

ImmunoGen

$2.30
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.04 (-1.50%) As of 10:26 AM EDT today
-$0.04 (-1.50%) Today

Why Robinhood?

You can buy or sell ImmunoGen and other stocks, options, ETFs, and crypto commission-free!

About IMGN

CEO
Employees
296
Headquarters
Founded
1981
Market Cap
348.16M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
2.51M
High Today
$2.35
Low Today
$2.28
Open Price
$2.31
Volume
178.65K
52 Week High
$10.39
52 Week Low
$1.76

Collections

Pharmaceutical
Biopharmaceutical
Biotechnology
Therapy
Cancer Prevention
Technology
Health
US

IMGN News

BenzingaJun 27

ImmunoGen To Focus Operations On Mivetuximab Soravtansine Development

1,890

IMGN Earnings

-$0.33
-$0.25
-$0.18
-$0.10
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.33 per share
Actual
Available Aug 2, Pre-Market

Popular Stocks

More IMGN News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.